Earnings Feed
Start Free
Home/Filings/4/0000864268-04-000011
4//SEC Filing

GLASSMAN DANIEL 4

Accession 0000864268-04-000011

CIK 0000864268other
View on SEC.govCompany Profile

Filed

Jan 25, 7:00 PM ET

Accepted

Jan 26, 3:47 PM ET

Size

22.4 KB

Accession

0000864268-04-000011

Insider Transaction Report

Form 4
Period: 2004-01-18
BRADLEY PHARMACEUTICALS INCBDY
GLASSMAN DANIEL
DirectorChairman, Pres. & CEO10% Owner
Transactions
  • Discretionary Transaction

    Common Stock

    2004-01-18$1.44/sh+150,000$216,555→ 267,811 total
  • Discretionary Transaction

    Stock Options (Right to buy)

    2004-01-18$1.44/sh−150,000$216,555→ 0 total
    Exercise: $1.44From: 2000-01-21Exp: 2004-01-20→ Common Stock (150,000 underlying)
Holdings

  • Stock Options (Right to buy)

    Exercise: $1.44From: 2000-12-05Exp: 2005-12-04→ Common Stock (341,589 underlying)
    341,589

  • Stock Options (Right to buy)

    Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (12,554 underlying)
    12,554

  • Common Stock

    (indirect: By DLD Partners)
    8,460

  • Stock Options (Right to buy)

    Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (31,279 underlying)
    31,279

  • Common Stock

    (indirect: By IRA)
    11,500

  • Common Stock

    (indirect: By 401(k))
    2,977

  • Stock Options (Right to buy)

    Exercise: $1.41From: 2003-09-12Exp: 2005-09-11→ Common Stock (18,000 underlying)
    18,000

  • Stock Options (Right to buy)

    Exercise: $1.17From: 2002-10-26Exp: 2004-10-25→ Common Stock (150,000 underlying)
    150,000

  • Stock Options (Right to buy)

    Exercise: $2.17From: 2001-02-23Exp: 2006-02-22→ Common Stock (25,000 underlying)
    25,000

  • Common Stock

    (indirect: By Spouse)
    13,880

  • Common Stock

    (indirect: By 401(k))
    10,818

  • Common Stock

    (indirect: By Foundation)
    16,000

  • Class B Common Stock

    309,361

  • Class B Common Stock

    (indirect: By Spouse)
    57,370

  • Class B Common Stock

    (indirect: By Banyan Communications Group, Inc.)
    16,005

  • Class B Common Stock

    (indirect: By Partnership)
    9,733

  • Stock Options (Right to buy)

    Exercise: $13.13From: 2005-03-22Exp: 2007-03-21→ Common Stock (315,000 underlying)
    315,000

Documents

1 file

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

→
Entity typeother

Related Parties

1
  • filerCIK 0000902023

Filing Metadata

Form type
4
Filed
Jan 25, 7:00 PM ET
Accepted
Jan 26, 3:47 PM ET
Size
22.4 KB
View on SEC.gov